How are checkpoint inhibitors changing the way RCC is treated?

How are checkpoint inhibitors changing the way RCC is treated?

obr

2 years
422 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute explains the use of checkpoint inhibitors is changing the treatment standards for renal cell carcinoma. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Up Next Autoplay